Fibrinogen-to-Albumin Ratio is Associated with All-Cause Mortality in Cancer Patients

BACKGROUND: Past studies have identified fibrinogen-to-albumin ratio (FAR) as a novel prognostic immune biomarker in various diseases. Here, we investigated the prognostic value of FAR in all combined cancer mortality. METHODS: We extracted patient data from the Multiparameter Intelligent Monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Yanling, Yang, Jingwen, Han, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407668/
https://www.ncbi.nlm.nih.gov/pubmed/34475778
http://dx.doi.org/10.2147/IJGM.S322735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407668/
https://www.ncbi.nlm.nih.gov/pubmed/34475778
http://dx.doi.org/10.2147/IJGM.S322735

Ejemplares similares